BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9011452)

  • 1. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
    Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
    Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
    Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.
    Eusufzai S; Ericsson S; Cederlund T; Einarsson K; Angelin B
    Gut; 1991 Sep; 32(9):1044-8. PubMed ID: 1916489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man.
    Marteau P; Chazouilléres O; Myara A; Jian R; Rambaud JC; Poupon R
    Hepatology; 1990 Nov; 12(5):1206-8. PubMed ID: 2227819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function.
    Nyhlin H; Brydon G; Danielsson A; Westman S
    Hepatogastroenterology; 1984 Aug; 31(4):187-91. PubMed ID: 6479839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cholestasis on absorption of ursodeoxycholic acid.
    Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
    Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the 75selenium homotaurocholic acid retention test (SeHCAT test) in diagnosis of diarrhea].
    Balzer K; Schmitt G; Reiners C; Goebell H
    Med Klin (Munich); 1995 Jan; 90(1):27-32. PubMed ID: 7885300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal bile acid malabsorption in cystic fibrosis.
    O'Brien S; Mulcahy H; Fenlon H; O'Broin A; Casey M; Burke A; FitzGerald MX; Hegarty JE
    Gut; 1993 Aug; 34(8):1137-41. PubMed ID: 8174969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 75SeHCAT retention half-life and fecal content of individual bile acids in patients with chronic diarrheal disorders.
    Scheurlen C; Kruis W; Büll U; Stellaard F; Lang P; Paumgartner G
    Digestion; 1986; 35(2):102-8. PubMed ID: 3770317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
    Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea.
    Brydon WG; Nyhlin H; Eastwood MA; Merrick MV
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lathosterol as a screening test for bile acid malabsorption due to ileal resection: correlation with 75SeHCAT test and faecal bile acid excretion.
    Färkkilä MA; Kairemo KJ; Taavitsainen MJ; Strandberg TA; Miettinen TA
    Clin Sci (Lond); 1996 Apr; 90(4):315-9. PubMed ID: 8777839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
    Stiehl A
    Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid malabsorption: a complication of conduit surgery.
    Durrans D; Wujanto R; Carroll RN; Torrance HB
    Br J Urol; 1989 Nov; 64(5):485-8. PubMed ID: 2611619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.
    Poupon R; Poupon RE
    Pharmacol Ther; 1995 Apr; 66(1):1-15. PubMed ID: 7630925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
    Jazrawi RP; de Caestecker JS; Goggin PM; Britten AJ; Joseph AE; Maxwell JD; Northfield TC
    Gastroenterology; 1994 Jan; 106(1):134-42. PubMed ID: 8276175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
    Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF
    Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictive factors for positive
    Murray IA; Murray LK; Woolson KL; Sherfi H; Dixon I; Palmer J; Sulkin T
    Scand J Gastroenterol; 2017; 52(6-7):698-703. PubMed ID: 28276822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study.
    Sciarretta G; Furno A; Morrone B; Malaguti P
    Am J Gastroenterol; 1994 Jul; 89(7):1058-61. PubMed ID: 8017365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.